Age-dependent tolerance to an endogenous tumor-associated antigen
- 28 March 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (15), 1863-1873
- https://doi.org/10.1016/j.vaccine.2008.01.052
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor MicroenvironmentClinical Cancer Research, 2007
- Mobilizing the low-avidity T cell repertoire to kill tumorsSeminars in Cancer Biology, 2007
- A decade of AIRENature Reviews Immunology, 2007
- Altered macrophage differentiation and immune dysfunction in tumor developmentJCI Insight, 2007
- Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulationThe Journal of Experimental Medicine, 2007
- Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccinesJCI Insight, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Initial sequencing and comparative analysis of the mouse genomeNature, 2002
- T Cell Response in Experimental Autoimmune Encephalomyelitis (EAE): Role of Self and Cross-Reactive Antigens in Shaping, Tuning, and Regulating the Autopathogenic T Cell RepertoireAnnual Review of Immunology, 2002
- In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.JCI Insight, 1998